Review
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Aug 26, 2014; 6(8): 847-854
Published online Aug 26, 2014. doi: 10.4330/wjc.v6.i8.847
Pseudoexfoliation syndrome and cardiovascular diseases
Georgios K Andrikopoulos, Dimitrios K Alexopoulos, Sotirios P Gartaganis
Sotirios P Gartaganis, Georgios K Andrikopoulos, Department of Ophthalmology, University of Patras Medical School, 26504 Patras, Greece
Dimitrios K Alexopoulos, Department of Internal Medicine, Division of Cardiology, University of Patras Medical School, 26504 Patras, Greece
Author contributions: Andrikopoulos GK, Alexopoulos DK and Gartaganis SP contributed to this paper.
Correspondence to: Sotirios P Gartaganis, MD, Emeritus Professor, Department of Ophthalmology, University of Patras, Medical School, 26504 Rion, Patras, Greece. s.gartag@med.upatras.gr
Telephone: +30-61-0271647 Fax: +30-61-0271647
Received: December 18, 2013
Revised: April 9, 2014
Accepted: June 10, 2014
Published online: August 26, 2014
Processing time: 272 Days and 16.5 Hours
Core Tip

Core tip: Although much remains to be clarified concerning causes, pathogenesis and systemic role of pseudoexfoliation aggregations, there is accumulating epidemiologic, clinical and laboratory evidence that this well-described clinical entity may occur as part of a systemic disorder with cardiovascular implications. The present review aims to summarize current knowledge on cardiovascular complications which have been associated with these suspicious whitish-gray deposits.